On Thursday shares of JPMorgan Chase & Co. (NYSE:JPM) closed at $63.81. Company’s sales growth for last 5 years was -4.90% and EPS growth for next 5 years is recorded as 8.15%. On 14 April, JPMorgan Chase & Co. (NYSE:JPM) has reported a 12.24 percent rise in profit for the quarter ended Mar. 31, 2015. The company has earned $5,914 million, or $1.45 a share in the quarter, compared with $5,269 million, or $1.28 a share for the same period last year.
Arrowhead Research Corp. (NASDAQ:ARWR) in last trading activity advanced 0.28% to close at $7.11. Company weekly performance is -10.57% while its quarterly performance stands at 5.96%. Arrowhead Research Corp. (NASDAQ:ARWR) is -59.18% away from its 52 week high. Arrowhead Research Corp (NASDAQ:ARWR) was downgraded by stock analysts at Jefferies Group from a “buy” rating to a “hold” rating in a report issued on Tuesday. They currently have a $9.00 price target on the stock. Jefferies Group’s price target suggests a potential upside of 12.50% from the stock’s previous close.
On last trading day OmniVision Technologies, Inc. (NASDAQ:OVTI) fell -0.23% to close at $26.39. Its volatility for the week is 1.46% while volatility for the month is 2.00%. OVTI’s sales growth for past 5 years was 23.40% and its EPS growth for past 5 years was 33.90%. OmniVision Technologies, Inc. (NASDAQ:OVTI) monthly performance is 3.37%. On 7 April, OmniVision Technologies, Inc. (NASDAQ:OVTI) announced a partnership to develop a battery- powered high definition (HD) video monitoring solution that enables OEMs to dramatically reduce time- to-market for wireless multi-node monitoring systems in homes and small businesses.
Silicon Motion Technology Corp. (NASDAQ:SIMO) has its institutional ownership stands at 48.70%. In last trading activity company’s stock closed at $34.09. Silicon Motion Technology Corp. (NASDAQ:SIMO) said that, it will release its full first quarter 2015 results after the market closes on April 27, 2015. The Company will host a conference call on April 28, at 8 am Eastern Time, to discuss its results.
On Thursday shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) closed at $9.10. Company’s sales growth for last 5 years was 66.20% and EPS growth for next 5 years is recorded as 41.40%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) announced its schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2015, taking place Saturday, April 18 through Wednesday, April 22, 2015, in Philadelphia.